CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
-
Published:2023-09-08
Issue:9
Volume:5
Page:369
-
ISSN:2434-0790
-
Container-title:Circulation Reports
-
language:en
-
Short-container-title:Circ Rep
Author:
Suwa Michihiro,Nohara Yuki,Morii Isao,Kino Masaya
Publisher
Japanese Circulation Society
Subject
Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology